Oliver Schacht is a businessperson who founded Epigenomics AG and who has been at the helm of 6 different companies. Currently, Dr. Schacht occupies the position of Chief Executive Officer & Director at OpGen, Inc., Chairman of Curetis USA, Inc. and Chief Executive Officer at Curetis GmbH (both are subsidiaries of OpGen, Inc.) and President & Director at BIO Deutschland. Oliver Schacht is also on the board of Protagen AG.
In the past Dr. Schacht held the position of Chief Executive Officer & Managing Director at Curetis NV and Director-Finance & Investor Relations at Epigenomics AG and Chief Executive Officer at Epigenomics, Inc. (a subsidiary of Epigenomics AG).
Dr. Schacht received a doctorate and a graduate degree from the University of Cambridge.